Literature DB >> 19876031

Novel pharmacotherapies for obesity poised to enter market.

Dan Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19876031     DOI： 10.1038/nrd3044

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  8 in total

1.  Intervention, integration and translation in obesity research: Genetic, developmental and metaorganismal approaches.

Authors:  Maureen A O'Malley; Karola Stotz
Journal:  Philos Ethics Humanit Med       Date:  2011-01-28       Impact factor: 2.464

2.  Market watch: upcoming market catalysts in Q3 2010.

Authors:  Michael Hay
Journal:  Nat Rev Drug Discov       Date:  2010-07       Impact factor: 84.694

3.  Rise and fall of anti-obesity drugs.

Authors:  Ming-Fang Li; Bernard My Cheung
Journal:  World J Diabetes       Date:  2011-02-15

4.  Prieurianin Causes Weight Loss in Diet-Induced Obese Mice and Inhibits Adipogenesis in Cultured Preadipocytes.

Authors:  Ahmed Kablan; Rudel A Saunders; Maria Szkudlarek-Mikho; Andrew J B Chin; Raul M Bosio; Kazuyuki Fujii; Joseph Shapiro; Khew-Voon Chin
Journal:  J Diabetes Metab       Date:  2010-09-29

Review 5.  Behavioral and pharmacologic therapies for obesity.

Authors:  Marion L Vetter; Lucy F Faulconbridge; Victoria L Webb; Thomas A Wadden
Journal:  Nat Rev Endocrinol       Date:  2010-08-03       Impact factor: 43.330

6.  Safety of antiobesity drugs.

Authors:  Bernard Man Yung Cheung; Tommy Tsang Cheung; Nithushi Rajitha Samaranayake
Journal:  Ther Adv Drug Saf       Date:  2013-08

Review 7.  The use of lorcaserin in the management of obesity: a critical appraisal.

Authors:  Bo Bai; Yu Wang
Journal:  Drug Des Devel Ther       Date:  2010-12-20       Impact factor: 4.162

Review 8.  Obesity pharmacotherapy: current perspectives and future directions.

Authors:  Monika Misra
Journal:  Curr Cardiol Rev       Date:  2013-02-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.